AnalystsPatrick R. TrucchioPatrick R. Trucchio's Stock Forecasts
AnalystsPatrick R. Trucchio
Sectors:
Industries:
Analyst Ranking
Top 15%
#766 out of 5290 analysts
Average Return
+12.73%
Win Rate
49%42 out of 85
Risk vs Reward
Poor
Good
Patrick R. Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alto Neuroscience IncANRO | +452.79% | $3.41 | $18.85 | 2025-08-17 - 2026-06-03 | Buy |
Arrowhead Pharmaceuticals IncARWR | +182.52% | $25.68 | $72.55 | 2025-09-01 - 2026-06-03 | Buy |
Nrx Pharmaceuticals IncNRXP | +125.00% | $1.80 | $4.05 | 2026-03-02 - 2026-06-03 | Buy |
Arrowhead Pharmaceuticals IncARWR | +96.40% | $36.94 | $72.55 | 2025-10-07 - 2026-06-03 | Buy |
Nrx Pharmaceuticals IncNRXP | +92.86% | $2.10 | $4.05 | 2025-12-15 - 2026-06-03 | Buy |
Patrick R. Trucchio Analyst Color
Get additional color on Patrick R. Trucchio's coverage of popular stocks
Patrick R. Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bright Minds Biosciences IncDRUG | 5 | Buy | $145.00 | N/A | Reiterates | 3 days ago |
Precision Biosciences IncDTIL | 1 | Buy | $60.00 | +893.38% | Reiterates | 8 days ago |
Gossamer Bio IncGOSS | 3 | Buy | $5.00 | +2,559.57% | Reiterates | 10 days ago |
Oncolytics Biotech IncONCY | 2 | Buy | $10.00 | +1,036.36% | Reiterates | 10 days ago |
Gh Research PLCGHRS | 3 | Buy | $65.00 | +166.07% | Maintains | 17 days ago |
Altimmune IncALT | 4 | Buy | $20.00 | +596.86% | Maintains | 17 days ago |
Alto Neuroscience IncANRO | 4 | Buy | $50.00 | +165.25% | Reiterates | 24 days ago |
Uniqure NvQURE | 8 | Buy | $50.00 | +67.34% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 6 | Buy | $510.00 | +74.31% | Reiterates | a month ago |
Assembly Biosciences IncASMB | 4 | Buy | $50.00 | +103.50% | Reiterates | a month ago |
Compass Pathways PLCCMPS | 2 | Buy | $70.00 | +451.62% | Reiterates | a month ago |
Nrx Pharmaceuticals IncNRXP | 6 | Buy | $45.00 | +1,011.11% | Reiterates | a month ago |
Immunocore Holdings PLCIMCR | 4 | Buy | $100.00 | +249.04% | Reiterates | a month ago |
Arrowhead Pharmaceuticals IncARWR | 6 | Buy | $100.00 | +37.84% | Reiterates | 2 months ago |
Ataibeckley IncATAI | 3 | Buy | $25.00 | +451.88% | Reiterates | 3 months ago |
Voyager Therapeutics IncVYGR | 3 | Buy | $25.00 | +594.44% | Reiterates | 3 months ago |
Silence Therapeutics PLCSLN | 2 | Buy | $75.00 | +1,070.05% | Reiterates | 3 months ago |
Aligos Therapeutics IncALGS | 3 | Buy | $50.00 | +872.76% | Reiterates | 3 months ago |
Vir Biotechnology IncVIR | 3 | Buy | $20.00 | +128.05% | Maintains | 3 months ago |
Pharvaris NvPHVS | 4 | Buy | $60.00 | +99.07% | Reiterates | 3 months ago |
Cybin IncHELP | 2 | Buy | $95.00 | +2,109.30% | Maintains | 3 months ago |
Definium Therapeutics IncDFTX | 1 | Buy | $70.00 | +196.74% | Maintains | 3 months ago |
Harmony Biosciences Holdings IncHRMY | 3 | Buy | $55.00 | +71.34% | Reiterates | 3 months ago |
Sangamo Therapeutics IncSGMO | 2 | Buy | $10.00 | +8,595.65% | Reiterates | 4 months ago |
Marker Therapeutics IncMRKR | 1 | Buy | $10.00 | +589.66% | Initiates Coverage On | 6 months ago |
Invivyd IncIVVD | 3 | Buy | $10.00 | +809.09% | Maintains | 7 months ago |
Beam Therapeutics IncBEAM | 2 | Buy | $80.00 | +170.73% | Reiterates | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.